Bringing the Oncology Community Together
Giants of Cancer Care 2015
mTOR Biology and the Growing Role for mTOR Inhibitors in the Management of Breast Cancer
The role of mTOR inhibition in breast cancer is evolving, and ongoing studies are evaluating biomarkers that will identify the patients who will benefit.
Advanced Bladder Cancer Increases Suicide Risk, Study Says
Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report.
Urologists in Cancer Care
SGR Repeal Bill Headed for Senate Following House Approval
A bill to repeal the SGR formula garnered critical support with a vote by the House of Representatives.
Role of Chemotherapy in CLL Shifts as Novel Agents Transform Clinical Practice
In an interview with OncLive, William G. Wierda, MD, PhD, discusses the changing role of chemotherapy in the management of CLL and the integration of novel agents into clinical practice.
Costly New Drugs Could Lead to Generation of Have-Nots in CLL
Ibrutinib and idelalisib will increase individual out-of-pocket and societal costs of caring for patients with CLL.
Frontline Pembrolizumab Bests Ipilimumab in Phase III Melanoma Trial
A trial comparing frontline pembrolizumab with ipilimumab for the treatment of advanced melanoma has met its progression-free survival and overall survival endpoints
Anti-PD-1 Therapy Poised to Take the Next Step in Melanoma
OncLive interviewed Jason J. Luke, MD, who discussed the clinical implications of immunotherapies in melanoma, with optimal sequencing and combinations emerging as the most pressing questions that researchers are seeking to answer in ongoing clinical trials.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.